<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Chem Cent J</journal-id><journal-id journal-id-type="iso-abbrev">Chem Cent J</journal-id><journal-title-group><journal-title>Chemistry Central Journal</journal-title></journal-title-group><issn pub-type="epub">1752-153X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5880794</article-id><article-id pub-id-type="publisher-id">407</article-id><article-id pub-id-type="doi">10.1186/s13065-018-0407-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Eugenol derivatives: synthesis, characterization, and evaluation of antibacterial and antioxidant activities</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>da Silva</surname><given-names>Francisco Felipe Maia</given-names></name><address><email>fmsilva1986@yahoo.com.br</email><email>felipe.maia@ifrn.edu.br</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Monte</surname><given-names>Francisco Jos&#x000e9; Queiroz</given-names></name><address><email>fmonte@dqoi.ufc.br</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>de Lemos</surname><given-names>Telma Leda Gomes</given-names></name><address><email>tlemos@dqoi.ufc.br</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>do Nascimento</surname><given-names>Patr&#x000ed;cia Georgina Garcia</given-names></name><address><email>georgina.quimica@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>de Medeiros Costa</surname><given-names>Alana Kelly</given-names></name><address><email>alanamedeiros17@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>de Paiva</surname><given-names>Luanda Misley Mota</given-names></name><address><email>lumisley@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Instituto Federal de Educa&#x000e7;&#x000e3;o, Ci&#x000ea;ncia e Tecnologia do Rio Grande do Norte (IFRN), RN 233, Km 02 N&#x000b0;999, Chapada do Apodi, Apodi, RN 59700-000 Brazil </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2160 0329</institution-id><institution-id institution-id-type="GRID">grid.8395.7</institution-id><institution>Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Qu&#x000ed;mica da Universidade Federal do Cear&#x000e1; (UFC), </institution></institution-wrap>Avenida Humberto Monte, S/N, Campus do pici, Fortaleza, CE 60455-900 Brazil </aff></contrib-group><pub-date pub-type="epub"><day>3</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>3</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>12</volume><elocation-id>34</elocation-id><history><date date-type="received"><day>8</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>27</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Eugenol is the major component of clove essential oil and has demonstrated relevant biological potential with well-known antimicrobial and antioxidant action. Therefore, this work carried out the synthesis, purification, characterization, and evaluation of the antioxidant and antibacterial potential of 19 eugenol derivatives. The derivatives were produced by esterification reactions in the hydroxyl group (&#x02212;OH) of eugenol with different carboxylic acids and also by addition reactions in the double bond of the allyl group. The derivatives had a promising antibacterial potential, including a lower minimum inhibitory concentration of 500&#x000a0;&#x003bc;g/mL than eugenol (1000&#x000a0;&#x003bc;g/mL). In addition, the derivatives were active against bacterial strains (<italic>Escherichia coli</italic>, <italic>Staphylococcus aureus</italic>) that eugenol itself showed no activity, thus increasing the spectrum of antibacterial action. As for the antioxidant activity, it was observed that the derivatives that involved esterification reactions in the hydroxyl group (&#x02212;OH) of the eugenol molecule&#x02019;s phenol resulted in a significant reduction of the antioxidant action (IC<sub>50</sub>&#x02009;&#x0003e;&#x02009;100&#x000a0;&#x003bc;g/mL) when compared with the eugenol precursor molecule (IC<sub>50</sub>&#x02009;=&#x02009;4.38&#x000a0;&#x003bc;g/mL). On the other hand, the structural changes located in the double bond affected much more smoothly the capacity of capturing radicals than the starting molecule, also being obtained derivatives with proximal antioxidant capacity (IC<sub>50</sub>&#x02009;=&#x02009;19.30&#x000a0;&#x003bc;g/mL) to commercial standards such as Trolox (IC<sub>50</sub>&#x02009;=&#x02009;16.00&#x000a0;&#x003bc;g/mL).</p><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s13065-018-0407-4) contains supplementary material, which is available to authorized users.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Molecular modification in structures of biologically active substances that occur naturally is one of the main strategies to enhance healthy biological effects, as well as to reduce eventual side effects [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. In 1998, it was estimated that 60% of the antitumor and anti-infective drugs that entered the market or under clinical trial originated from natural products [<xref ref-type="bibr" rid="CR4">4</xref>] via structural modifications. More recent data (December 2014) show that of the 237 drugs used as anti-infectious agents (antibacterial, antifungal, parasitic, and antiviral), excluding vaccines, recognized by public health agencies in the world, 138 (approximately 58.30%) are products of natural origin or derived from natural products. Thus, it is clear that this is a line of research with great potential for obtaining new drugs [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par3">Eugenol, a natural substance used as a target molecule for the manufacture of bioactive compounds, was first isolated in 1929 and its commercial production began in 1940 in the United States. It can be produced synthetically; however, it is mainly extracted from <italic>Ocimum tenuiflorum</italic>, <italic>Cassia fistula</italic>, <italic>Zieria smithii</italic>, and <italic>Pimenta racemosa</italic>. Classified as a phenylpropanoid of the allyl-phenol type, eugenol is a pale yellow oil with clove odor and spicy taste. With numerous applications in the pharmaceutical, food, agricultural, and cosmetics industries [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>], it showed promising antimicrobial and antioxidant effects [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>], when evaluated against the fungi <italic>Cladosporium</italic> spp. [<xref ref-type="bibr" rid="CR13">13</xref>]. Other activities are reported in literature, such as antiviral [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], anti-inflammatory [<xref ref-type="bibr" rid="CR16">16</xref>], and inhibitor of platelet aggregation [<xref ref-type="bibr" rid="CR17">17</xref>]. In addition, its anti-Leishmania activity together with its low cytotoxicity qualifies it as a promising source of new leishmanicidal [<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par4">This broad spectrum of biological activity makes eugenol a target molecule for structural modifications in order to produce substances with therapeutic properties. Currently, among the various clinical pathologies, bacterial infections and cellular oxidation stand out, both with serious implications for public health. Due to the acquisition of resistance and the mutational capacity of microorganisms, commercial antibiotics are in many cases incapable of fighting bacterial proliferation, resulting in failures in the treatment associated with multiresistant bacteria. Consequently, bacterial resistance has become a global concern regarding public health [<xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par5">Aerobic organisms have the ability to produce free radicals that, in excess, can initiate chain reactions that damage cells or cause death to the latter. As a consequence, several diseases arise, especially cardiovascular and neurodegenerative diseases. The fight against the effects resulting from the production of free radicals has been the dietary use of antioxidant substances with a significant effect in the prevention of these diseases [<xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref>]. Eugenol, according to reports in literature, combats oxidative stress with beneficial effects on health.</p><p id="Par6">Thus, in view of the broad spectrum of biological activities of eugenol, the present study aimed to obtain its derivatives by means of esterification and addition reactions. All were submitted to the evaluation of the antibacterial and antioxidant potential with very interesting results.</p></sec><sec id="Sec2"><title>Results and discussion</title><p id="Par7">Structural modifications from eugenol, carried out on the hydroxyl group and the olefinic bond, were represented in reaction Schemes&#x000a0;<xref rid="Sch1" ref-type="fig">1</xref> and <xref rid="Sch2" ref-type="fig">2</xref>, respectively.<fig id="Sch1"><label>Scheme&#x000a0;1</label><caption><p>Eugenol derivatives (<bold>1&#x02013;11</bold>) through reactions in the hydroxyl groups</p></caption><graphic xlink:href="13065_2018_407_Sch1_HTML" id="MO1"/></fig>
<fig id="Sch2"><label>Scheme&#x000a0;2</label><caption><p>Eugenol derivatives (<bold>12&#x02013;19)</bold> through reactions in the double bond</p></caption><graphic xlink:href="13065_2018_407_Sch2_HTML" id="MO2"/></fig>
</p><p id="Par8">Among the compounds prepared, 3, 13, 15, 17, 18, 19 are unpublished in literature. Compounds 1, 2, 4, 5, 6, 7, 8, 9, 10&#x000a0;and 11 have already been prepared in previous works [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>], however through different synthetic routes.</p><p id="Par9">Evaluation of the antibacterial activity of eugenol derivatives using the inhibition zone technique, measured in millimeter (mm), demonstrates the potential for inhibition of microbial growth by a given substance. According to literature, substances with inhibition halos less than 7&#x000a0;mm, greater than 7 and less than 16&#x000a0;mm, and greater than 16&#x000a0;mm are considered inactive, moderately active, and antibacterial potential, respectively [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. The results presented in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> show the inhibition zones (halos) presented by the eugenol derivatives against six bacterial strains.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Effect of eugenol derivatives against six bacterial strains</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Compound</th><th align="left" colspan="6">Zone of inhibition (mm)</th></tr><tr><th align="left">
<italic>Pseudomonas aeruginosa</italic>
</th><th align="left">
<italic>Escherichia coli</italic>
</th><th align="left">
<italic>Staphylococcus aureus</italic>
</th><th align="left">
<italic>Streptococcus</italic>
</th><th align="left">
<italic>Klebsiella pneumoniae</italic>
</th><th align="left">
<italic>Bacillus cereus</italic>
</th></tr></thead><tbody><tr><td align="left">
<bold>1</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>2</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>3</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>4</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">12</td></tr><tr><td align="left">
<bold>5</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">6</td><td char="." align="char">0</td><td char="." align="char">12</td></tr><tr><td align="left">
<bold>6</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>7</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>8</bold>
</td><td char="." align="char">0</td><td char="." align="char">12</td><td char="." align="char">6</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>9</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">11</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>10</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">12</td><td char="." align="char">6</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>11</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>12</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">10</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>13</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">12</td><td char="." align="char">0</td><td char="." align="char">8</td></tr><tr><td align="left">
<bold>14</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">9</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>15</bold>
</td><td char="." align="char">0</td><td char="." align="char">12</td><td char="." align="char">0</td><td char="." align="char">10</td><td char="." align="char">6</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>16</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">10</td><td char="." align="char">10</td><td char="." align="char">15</td><td char="." align="char">20</td></tr><tr><td align="left">
<bold>17</bold>
</td><td char="." align="char">6</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">10</td><td char="." align="char">6</td><td char="." align="char">12</td></tr><tr><td align="left">
<bold>18</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">9</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">
<bold>19</bold>
</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">Methyl eugenol</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">Eugenol</td><td char="." align="char">12</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">6</td><td char="." align="char">11</td><td char="." align="char">12</td></tr><tr><td align="left">Isoeugenol</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">12</td><td char="." align="char">0</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td align="left">Tetracycline</td><td char="." align="char">0</td><td char="." align="char">10</td><td char="." align="char">20</td><td char="." align="char">10</td><td char="." align="char">9</td><td char="." align="char">10</td></tr></tbody></table></table-wrap>
</p><p id="Par10">According to the results (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>), acetylation of eugenol did not result in any benefit, since esters <bold>1</bold>, <bold>2</bold>, and <bold>3</bold> showed no antibacterial action against any of the strains. Also, esterification with benzoic acid and its <italic>p</italic>-substituted derivatives yielded derivatives <bold>4</bold>&#x02013;<bold>9</bold> which exhibited random but still insufficient activities relative to eugenol itself.</p><p id="Par11">Regarding derivatives <bold>10</bold>&#x02013;<bold>18</bold> resulting from double bond addition, <bold>10</bold>&#x02013;<bold>14</bold>, <bold>17</bold>, and <bold>18</bold> showed random and insufficient activities relative to eugenol. However, according to the classification shown above, derivative <bold>16</bold> showed a strong antibiotic effect against <italic>Bacillus cereus</italic> and a moderate effect against <italic>Staphylococcus aureus</italic>, <italic>Streptococcus</italic>, and <italic>Klebsiella pneumoniae</italic>, but was inactive in cases of <italic>Pseudomonas aeruginosa</italic> and <italic>Escherichia coli</italic>. It was of interest to observe that compound <bold>16</bold>, except for the bacterium <italic>P. aeruginosa</italic>, showed greater activity than eugenol itself. In the case of derivative <bold>15</bold>, a triacetyl derivative, it is of particular interest to highlight the high antibacterial activity (inhibition halo 12) against <italic>E. coli</italic> relative to eugenol (inhibition halo 0). By contrast, 1<bold>5</bold> was inactive (inhibition halo 0) against <italic>P. aeruginosa</italic>, whereas eugenol was active (inhibition halo 12).</p><p id="Par12">A recent work [<xref ref-type="bibr" rid="CR34">34</xref>] revealed antimicrobial activity for eugenol against strains <italic>E. coli</italic> and <italic>S. aureus</italic>, exhibiting inhibition halos with diameters of 9.25 and 7.75&#x000a0;mm, respectively. Although the results in the present study did not show activity for these strains, it is worth mentioning that the amounts (3&#x000a0;mg) applied in the first one were 13 times higher than those (0.2&#x000a0;mg) used in the present study. Of the derivatives priorly mentioned, those with inhibition halos greater than 6&#x000a0;mm were subjected to microdilution tests to determine the minimum inhibitory concentration (MIC) which prevents visible growth of the bacteria. Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> shows the results for derivatives <bold>4</bold>&#x02013;<bold>18</bold> expressed in &#x003bc;g/mL.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Minimum inhibitory concentration (MIC) presented by derivatives 1&#x02013;19 against different bacterial strains</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Compound</th><th align="left" colspan="6">Minimum inhibitory concentration MIC (&#x000b5;g/mL)</th></tr><tr><th align="left">
<italic>Pseudomonas aeruginosa</italic>
</th><th align="left">
<italic>Escherichia coli</italic>
</th><th align="left">
<italic>Staphylococcus aureus</italic>
</th><th align="left">
<italic>Streptococcus</italic>
</th><th align="left">
<italic>Klebsiella pneumoniae</italic>
</th><th align="left">
<italic>Bacillus cereus</italic>
</th></tr></thead><tbody><tr><td align="left">
<bold>4</bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">
<bold>5</bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">1000</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">
<bold>8</bold>
</td><td align="left">NA</td><td align="left">500</td><td align="left">1000</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">
<bold>9</bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">1000</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">
<bold>10</bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">1000</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">
<bold>12</bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">1000</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">
<bold>13</bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">1000</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">
<bold>14</bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">
<bold>15</bold>
</td><td align="left">NA</td><td align="left">1000</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">
<bold>16</bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">500</td><td align="left">500</td></tr><tr><td align="left">
<bold>17</bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">1000</td></tr><tr><td align="left">
<bold>18</bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">
<bold>19</bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">Eugenol</td><td align="left">1000</td><td align="left">NA</td><td align="left">NA</td><td align="left">1000</td><td align="left">1000</td><td align="left">1000</td></tr><tr><td align="left">Isoeugenol</td><td align="left">NA</td><td align="left">NA</td><td align="left">1000</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">Penicillin/erythromycin</td><td align="left">125</td><td align="left">250</td><td align="left">250</td><td align="left">250</td><td align="left">250</td><td align="left">62.5</td></tr></tbody></table><table-wrap-foot><p><italic>NA</italic> no activity at the concentrations analyzed</p></table-wrap-foot></table-wrap>
</p><p id="Par13">Among the compounds tested, <bold>8</bold> and <bold>16</bold> showed the highest activity in inhibiting the strains. Compound <bold>16</bold> had the highest activity of all the derivatives involved in this study, and regarding <italic>K. pneumoniae</italic> and <italic>B. cereus</italic> strains, it was two times more active than eugenol. In contrast, compound <bold>8</bold> exhibited, in comparative terms, strong antibiotic activity against the <italic>E. coli</italic> strain, where the eugenol itself is inactive. Whereas epoxide <bold>16</bold> from eugenol showed strong relative activity, the corresponding acetate <bold>17</bold> showed a marginal effect.</p><p id="Par14">In previous work [<xref ref-type="bibr" rid="CR35">35</xref>], an MIC of 1200&#x000a0;&#x003bc;g/mL was recorded for eugenol against <italic>S. aureus</italic> bacteria, consistent with an MIC of 1000&#x000a0;&#x003bc;g/mL determined in the present study. These comparative data show that, like eugenol, several of its derivatives have a promising antimicrobial potential.</p><p id="Par15">The antioxidant activity of eugenol derivatives was evaluated with DPPH (2,2-diphenyl-1-picrylhydrazyl). Radical scavenging activity is one of the most widely used methods for screening the antioxidant activity of substances. The ability to capture free radicals by the eugenol derivatives (<bold>1</bold>&#x02013;<bold>19</bold>) against DPPH was expressed as IC<sub>50</sub>, which represents the concentration required to capture 50% of the radicals in the medium. As positive controls, Trolox and gallic acid were used. Phenolic compounds, such as eugenol, have the facility of transferring electrons or hydrogen atoms by neutralizing free radicals, that is, by blocking the oxidative process [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. The results (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>) showed that all the derivatives (<bold>1</bold>&#x02013;<bold>19</bold>) presented higher IC<sub>50</sub> than eugenol, that is, the structural modifications resulted in substances with lower antioxidant effects. All derivatives (<bold>1</bold>&#x02013;<bold>11, 13, 15, 17, 20</bold> and <bold>21</bold>) produced by the esterification reaction on the hydroxyl group showed a strong reduction in antioxidant activity, as expected [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>].<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Inhibitory concentration of 50% (IC<sub>50</sub>) of the free radicals presented by the eugenol derivatives</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Substance</th><th align="left">IC<sub>50</sub> (&#x003bc;g/mL)</th></tr></thead><tbody><tr><td align="left">
<bold>1</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>2</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>3</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>4</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>5</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>6</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>7</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>8</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>9</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>10</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>11</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>12</bold>
</td><td align="left">51.12</td></tr><tr><td align="left">
<bold>13</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>14</bold>
</td><td align="left">20</td></tr><tr><td align="left">
<bold>15</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>16</bold>
</td><td align="left">19.3</td></tr><tr><td align="left">
<bold>17</bold>
</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">
<bold>18</bold>
</td><td align="left">32</td></tr><tr><td align="left">
<bold>19</bold>
</td><td align="left">30.37</td></tr><tr><td align="left">Methyl eugenol</td><td align="left">&#x0003e;&#x02009;100</td></tr><tr><td align="left">Isoeugenol</td><td align="left">50.7</td></tr><tr><td align="left">Eugenol</td><td align="left">4.38</td></tr><tr><td align="left">Gallic acid</td><td align="left">0.64</td></tr><tr><td align="left">Trolox</td><td align="left">16</td></tr></tbody></table></table-wrap>
</p><p id="Par16">In the specific case of eugenol, the relationship between the hydroxyl group and the antioxidant action was observed in a previous study [<xref ref-type="bibr" rid="CR26">26</xref>] through derivatives <bold>2</bold>, <bold>4</bold>, <bold>5</bold>, <bold>6</bold>, and <bold>9</bold>, in which all presented IC<sub>50</sub> is lower than eugenol.</p><p id="Par17">On the other hand, the chemical modification in the double bond, in the case of the derivatives <bold>12</bold>, <bold>14</bold>, <bold>16</bold>, <bold>18</bold>, and <bold>19</bold>, also caused reduction in the antioxidant capacity against the radical DPPH, however, much lower than that caused by the esterification of the hydroxyl group. Thus, derivatives <bold>16</bold> (IC<sub>50</sub> 19.3&#x000a0;&#x003bc;g/mL) and <bold>18</bold> (IC<sub>50</sub> 32&#x000a0;&#x003bc;g/mL), for example, showed antioxidant action close to the Trolox standard (IC<sub>50</sub> 16&#x000a0;&#x003bc;g/mL).</p><p id="Par18">Derivatives <bold>12</bold>, <bold>14</bold>, <bold>16</bold>, <bold>18</bold>, and <bold>19</bold>, with higher antioxidant action than the others, have a structural characteristic capable of enhancing this action. Although with IC<sub>50</sub> values higher than eugenol, the results reflect the behavior of the substances in vitro; however, in living biological systems, the antioxidant activity varies, among others, with factors such as the reduction potential in the medium, the displacement capacity of the radical structure formed, the ability to complex transition metals involved in the oxidative process, access to the site of action according to hydrophilicity or lipophilicity, and its partition coefficient [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. The partition coefficient is closely related to the hydrophilic (or hydrophobic) character of the molecule. In the case of derivatives <bold>12</bold>, <bold>14</bold>, <bold>16</bold>, <bold>18</bold>, and <bold>19</bold>, although less active than eugenol, the hydrophilicity is substantially different, especially for <bold>12</bold> and <bold>14</bold>, which have additional hydroxyl groups allowing a higher degree of hydration and, consequently, greater interaction in aqueous media.</p></sec><sec id="Sec3"><title>Conclusions</title><p id="Par19">It was possible to demonstrate that structural modifications in the eugenol molecule resulted in some potentially antibacterial substances (e.g., <bold>8</bold>, <bold>15</bold>, <bold>16</bold>). In addition, various derivatives (<bold>9</bold>, <bold>10</bold>, <bold>12</bold>, <bold>13</bold>, <bold>14</bold>, <bold>15</bold>, <bold>16</bold>, <bold>17</bold>, and <bold>18</bold>) have greater power in inhibiting the growth of certain strains regarding eugenol, as in the case of <italic>Streptococcus</italic> bacteria.</p><p id="Par20">Regarding the antioxidant capacity of the derivatives, the study contributed to make an empirical evaluation of the structure&#x02013;activity relationship, being observed that the hydroxyl group is decisive in inhibiting the propagation of free radicals. On the other hand, changes in the olefinic bond, although resulting in a slight reduction in the capacity to capture DPPH radicals, and the increase in the hydrophilic character can compensate and contribute as a differential in the antioxidant action.</p></sec><sec id="Sec4"><title>Experimental</title><sec id="Sec5"><title>General methods</title><p id="Par21">GC&#x02013;MS analyses were performed using a Shimadzu QP2010SE Plus instrument equipped with a Rtx<sup>&#x000ae;</sup>-5MS (5% phenyl)-dimethylpolysiloxane capillary column (30&#x000a0;m&#x02009;&#x000d7;&#x02009;0.25&#x000a0;mm) with a film thickness of 0.1&#x000a0;&#x000b5;m using He as carrier gas (1.0&#x000a0;mL/min) in split mode; the injector and detector temperatures were 240 and 280&#x000a0;&#x000b0;C, respectively; column temperature was programmed at 5&#x000a0;&#x000b0;C/min from 60 to 80&#x000a0;&#x000b0;C (3&#x000a0;min), then at 30&#x000a0;&#x000b0;C/min to 280&#x000a0;&#x000b0;C (10&#x000a0;min). Mass spectra were recorded on a Shimadzu QP2010SE apparatus operating in electron impact mode at 70&#x000a0;eV (<italic>scan</italic> mode analysis). <sup>1</sup>H NMR spectra were recorded on a Bruker DPX 300 (300&#x000a0;MHz) and a Bruker DRX 500 (500&#x000a0;MHz) NMR, using CDCl<sub>3</sub> solutions and TMS as internal standard.</p></sec><sec id="Sec6"><title>Synthesis of eugenol derivatives: (<bold>1</bold>&#x02013;<bold>3</bold>)</title><p id="Par22">In separate experiments, eugenol (328&#x000a0;mg, 2&#x000a0;mmol) was mixed with acetic anhydride (712&#x000a0;mg, 6&#x000a0;mmol), butanoic anhydride (948&#x000a0;mg, 6&#x000a0;mmol), and hexanoic anhydride (1284&#x000a0;mg, 6&#x000a0;mmol). In each mixture, 2&#x000a0;mL of pyridine was added, followed by stirring of the resulting solutions for 24&#x000a0;h at room temperature. At the end of this period, EtOAc (20&#x000a0;mL) was added to the reaction medium, which was then partitioned with a 20% (w/v) aqueous solution of CuSO<sub>4</sub>&#x000b7;5H<sub>2</sub>O (3&#x02009;&#x000d7;&#x02009;30&#x000a0;mL). After separation of the EtOAc and H<sub>2</sub>O phases, the organic was washed with saturated NaCl solution (3&#x02009;&#x000d7;&#x02009;10&#x000a0;mL) and dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated under reduced pressure to obtain the compounds <bold>1</bold> (362&#x000a0;mg, 1.76&#x000a0;mmol, 88% yield), <bold>2</bold> (337&#x000a0;mg, 1.44&#x000a0;mmol, 72% yield), and <bold>3</bold> (314.4&#x000a0;mg, 1.2&#x000a0;mmol, 60% yield). <bold>4</bold>&#x02013;<bold>11</bold>: In individual experiments, a mixture of eugenol (328&#x000a0;mg, 2&#x000a0;mmol), DMAP (50&#x000a0;mg, 0.4&#x000a0;mmol), and DCC (118&#x000a0;mg, 3&#x000a0;mmol) was added to benzoic acid (366&#x000a0;mg, 3&#x000a0;mmol), 4-methylbenzoic acid (432&#x000a0;mg, 3&#x000a0;mmol), 4-fluorobenzoic acid (420&#x000a0;mg, 3&#x000a0;mmol), 4-chlorobenzoic acid (469.5&#x000a0;mg, 3&#x000a0;mmol), 4-bromobenzoic acid (603&#x000a0;mg, 3&#x000a0;mmol), 4-nitrobenzoic acid (501&#x000a0;mg, 3&#x000a0;mmol), <italic>trans</italic>-cinnamic acid (444&#x000a0;mg, 3&#x000a0;mmol), and 2-(4-isopropylphenyl)propanoic acid (ibuprofen, 618&#x000a0;mg, 3&#x000a0;mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5&#x000a0;mL). The reaction mixtures were stirred at room temperature for 24&#x000a0;h. At the end of this period, each reaction mixture was filtered and the liquid phases were washed successively with 5% (m/v) HCl (2&#x02009;&#x000d7;&#x02009;5&#x000a0;mL), 5% NaHCO<sub>3</sub> (w/v; 3&#x02009;&#x000d7;&#x02009;5&#x000a0;mL), and H<sub>2</sub>O (3&#x02009;&#x000d7;&#x02009;5&#x000a0;mL). Finally, after drying with anhydrous Na<sub>2</sub>SO<sub>4</sub>, the organic phases were evaporated under reduced pressure to afford <bold>4</bold> (353&#x000a0;mg, 1.32&#x000a0;mmol, 66% yield), <bold>5</bold> (350&#x000a0;mg, 1.24&#x000a0;mmol, 62% yield), <bold>6</bold> (457.6&#x000a0;mg, 1.6&#x000a0;mmol, 80% yield), <bold>7</bold> (453&#x000a0;mg, 1.5&#x000a0;mmol, 75% yield), <bold>8</bold> (484&#x000a0;mg, 1.4&#x000a0;mmol, 70% yield), <bold>9</bold> (438&#x000a0;mg, 1.4&#x000a0;mmol, 70% yield), <bold>10</bold> (376&#x000a0;mg, 1.28&#x000a0;mmol, 64% yield), and <bold>11</bold> (422&#x000a0;mg, 1.2&#x000a0;mmol, 60% yield) [<xref ref-type="bibr" rid="CR41">41</xref>]. <bold>12</bold>: To a stirred yellow-colored solution of HgSO<sub>4</sub> (1483&#x000a0;mg, 5&#x000a0;mmol) in water (5&#x000a0;mL) and THF (5&#x000a0;mL) was added eugenol (820&#x000a0;mg, 5&#x000a0;mmol). After disappearance of the yellow coloration (ca. 4&#x000a0;h) a mixture of 3&#x000a0;M aqueous NaOH (5&#x000a0;mL) and 0.5&#x000a0;M NaBH<sub>4</sub> (5&#x000a0;mL) was added, followed by vigorous stirring for 30&#x000a0;min. At the end of this period, the reaction mixture was poured into a saturated aqueous solution of NaCl (20&#x000a0;mL) and extracted with THF (3&#x02009;&#x000d7;&#x02009;5&#x000a0;mL). The combined extracts were dried in anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to give a residue (637&#x000a0;mg) which was chromatographed over Si gel column to give <bold>12</bold> (318&#x000a0;mg, 1.75&#x000a0;mmol, 35% yield) [<xref ref-type="bibr" rid="CR42">42</xref>]. <bold>13</bold>: A solution of <bold>12</bold> (182&#x000a0;mg, 1&#x000a0;mmol) in a mixture of Ac<sub>2</sub>O (612&#x000a0;mg, 6&#x000a0;mmol) and C<sub>5</sub>H<sub>5</sub>N (1&#x000a0;mL) was stirred for 24&#x000a0;h at room temperature. At the end of this period [complete acetylation was indicated by TLC (Si gel, hexane&#x02013;EtOAc 7:3)], EtOAC (20&#x000a0;mL) was added to the reaction medium, which was then partitioned with a 20% (w/v) aqueous solution of CuSO<sub>4</sub>&#x000b7;5H<sub>2</sub>O (3&#x02009;&#x000d7;&#x02009;5&#x000a0;mL). After separation of the EtOAc and H<sub>2</sub>O phases, the organic phase was dried with anhydrous Na<sub>2</sub>SO<sub>4</sub> and the solvent evaporated under reduced pressure <bold>13</bold> (127&#x000a0;mg, 0.48&#x000a0;mmol, 48% yield) [<xref ref-type="bibr" rid="CR43">43</xref>]. <bold>14</bold>: Eugenol (820&#x000a0;mg, 5&#x000a0;mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5&#x000a0;mL) was added dropwise to <italic>m</italic>-chloroperbenzoic acid (1.30&#x000a0;g) in CH<sub>2</sub>Cl<sub>2</sub> (15&#x000a0;mL) at 25&#x000a0;&#x000b0;C. After stirring for 24&#x000a0;h, 10% aq. Na<sub>2</sub>SO<sub>3</sub> (10&#x000a0;mL) was added to the mixture and the solution was washed two times with 5% NaHCO<sub>3</sub> (25&#x000a0;mL). The CH<sub>2</sub>Cl<sub>2</sub> layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated [<xref ref-type="bibr" rid="CR44">44</xref>]. The reaction product (360&#x000a0;mg, 2&#x000a0;mmol) in 20% NaOH (10&#x000a0;mL) was heated at 80&#x000a0;&#x000b0;C for 2&#x000a0;h. The reaction mixture was cooled (28&#x000a0;&#x000b0;C), diluted with water, and neutralized with 10% HCl to pH 7.0. The water was removed under reduced pressure and the resultant mass was extracted with anhydrous EtOH (5&#x02009;&#x000d7;&#x02009;10&#x000a0;mL). The ethanolic solution was filtered, dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to give a crude product which was subsequently chromatographed over Si gel column <bold>14</bold> (435.6&#x000a0;mg, 2.2&#x000a0;mmol, 44% yield). <bold>15</bold>: Product <bold>14</bold> (198&#x000a0;mg, 1&#x000a0;mmol) was treated with Ac<sub>2</sub>O (1020&#x000a0;mg, 10&#x000a0;mmol) and anhydrous pyridine (3&#x000a0;mL). The resultant solution was stirred at room temperature for 24&#x000a0;h. After this time, the reaction was complete, as indicated by TLC [Si gel, hexane&#x02013;EtOAc (7:3)], and EtOAC (20&#x000a0;mL) was added to the reaction medium, which was then partitioned with a 20% (w/v) aqueous solution of CuSO<sub>4</sub>&#x000b7;5H<sub>2</sub>O (5&#x02009;&#x000d7;&#x02009;10&#x000a0;mL). After separation of the EtOAc and H<sub>2</sub>O phases, the organic was dried with anhydrous Na<sub>2</sub>SO<sub>4</sub> and the solvent evaporated under reduced pressure to afford <bold>15</bold> (110&#x000a0;mg, 0.34&#x000a0;mmol, 34% yield). <bold>16</bold>: Eugenol (820&#x000a0;mg) in CH<sub>2</sub>Cl<sub>2</sub> (5&#x000a0;mL) was added dropwise to <italic>m</italic>-chloroperbenzoic acid (1.30&#x000a0;g) in CH<sub>2</sub>Cl<sub>2</sub> (15&#x000a0;mL) at 25&#x000a0;&#x000b0;C. After stirring for 24&#x000a0;h, 10% aq. Na<sub>2</sub>SO<sub>3</sub> (10&#x000a0;mL) was added to the mixture and the solution was washed two times with 5% NaHCO<sub>3</sub> (25&#x000a0;mL). The CH<sub>2</sub>Cl<sub>2</sub> layer was dried with Na<sub>2</sub>SO<sub>4</sub> and concentrated. The residue was purified by silica gel CC with hexane/ethyl acetate (90:10) to give <bold>7</bold> (1.00&#x000a0;g) and <bold>16</bold> (328&#x000a0;mg, 2&#x000a0;mmol, 40% yield). <bold>17:</bold> A solution of <bold>16</bold> (180&#x000a0;mg, 1&#x000a0;mmol) in a mixture of Ac<sub>2</sub>O (306&#x000a0;mg, 3&#x000a0;mmol) and C<sub>5</sub>H<sub>5</sub>N (0.5&#x000a0;mL) was stirred under ice bath for 3&#x000a0;h. After this time, the reaction was complete, as indicated by TLC [Si gel, hexane&#x02013;EtOAc (8:2)], and EtOAc (20&#x000a0;mL) was added to the reaction medium, which was then partitioned with a 20% (w/v) aqueous solution of CuSO<sub>4</sub>&#x000b7;5H<sub>2</sub>O (3&#x02009;&#x000d7;&#x02009;5&#x000a0;mL). After separation of the EtOAc and H<sub>2</sub>O phases, the organic was dried with anhydrous Na<sub>2</sub>SO<sub>4</sub> and the solvent evaporated under reduced pressure to afford <bold>17</bold> (138&#x000a0;mg, 0.62&#x000a0;mmol, 62% yield). <bold>18</bold>: To a stirred solution of ZnCl<sub>2</sub> (0.634&#x000a0;g, 4.95&#x000a0;mmol) in acetone (5&#x000a0;mL) at 0&#x000a0;&#x000b0;C was added over a period of 10&#x000a0;min the compound <bold>14</bold> (396&#x000a0;mg, 2&#x000a0;mmol). The reaction mixture was then warmed at 30&#x000a0;&#x000b0;C, where stirring was continued for an additional time of 24&#x000a0;h. The reaction was quenched by the addition of a mixture of CHCl<sub>3</sub> (10&#x000a0;mL) and saturated aqueous NaCl (10&#x000a0;mL) and extracted with CHCl<sub>3</sub> (3&#x02009;&#x000d7;&#x02009;10&#x000a0;mL). The organic phases were dried with anhydrous Na<sub>2</sub>SO<sub>4</sub> and the solvent evaporated under reduced pressure to afford <bold>18</bold> (285.6&#x000a0;mg, 1.2&#x000a0;mmol, 60% yield) [<xref ref-type="bibr" rid="CR45">45</xref>]. <bold>19</bold>: Compound <bold>18</bold> (238&#x000a0;mg, 1&#x000a0;mmol) was treated with Ac<sub>2</sub>O (306&#x000a0;mg, 3&#x000a0;mmol) and anhydrous pyridine (1&#x000a0;mL). The resultant solution was stirred at room temperature for 18&#x000a0;h. After this time, the reaction was complete, as indicated by TLC [Si gel, hexane&#x02013;EtOAc (8:2)], and EtOAC (20&#x000a0;mL) was added to the reaction medium, which was then partitioned with a 20% (w/v) aqueous solution of CuSO<sub>4</sub>&#x000b7;5H<sub>2</sub>O (3&#x02009;&#x000d7;&#x02009;10&#x000a0;mL). After separation of the EtOAc and H<sub>2</sub>O phases, the organic was dried with anhydrous Na<sub>2</sub>SO<sub>4</sub> and the solvent evaporated under reduced pressure to afford <bold>19</bold> (196&#x000a0;mg, 0.7&#x000a0;mmol, 62% yield). The characterization of derivatives is detailed in Additional file <xref rid="MOESM1" ref-type="media">1</xref>.</p></sec><sec id="Sec7"><title>Antibacterial activity of eugenol derivatives by inhibition zone (disk diffusion)</title><p id="Par23">Quantitative and qualitative antibacterial screening was performed in the Federal Institute of Education, Science and Technology of Rio Grande do Norte, Apodi campus. The procedure consisted of testing the pure compounds against the following microorganisms, obtained from according to norms approved by the National Sanitary Surveillance Agency<sup>32</sup>: <italic>Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Streptococcus, Klebsiella pneumoniae, Bacillus cereus</italic>. The bacterial strains were replicated in Muller Hilton agar medium (MH) and incubated for 24&#x000a0;h at 35&#x000a0;&#x000b0;C. Plates for the assay were prepared by dispersing the Muller Hilton agar medium in sterile Petri dishes and the bacteria were incubated at 35&#x000a0;&#x000b0;C. Then, with the help of a flame-sterilized platinum handle, the bacterial cells were transferred to a sterile test tube containing 0.85% NaCl solution until reaching an absorption between 0.08 and 0.10 in a spectrophotometer at the wavelength of 625&#x000a0;nm (corresponding to approximately 1&#x02009;&#x000d7;&#x02009;10<sup>8</sup> cells). In the process, a sterile swab was soaked in the bacterial suspension and compressed into the whole assay to avoid excess material. This was then applied in uniform motions on the culture medium until the entire surface was filled. For the disks, 20&#x000a0;&#x000b5;L of the pure compounds was added at concentrations of 10&#x000a0;mg/mL in DMSO/water (1:1). The plates prepared as described were incubated at 35&#x000a0;&#x000b0;C. The antimicrobial activity was recorded as the width (in mm) of the inhibition zone after 24&#x000a0;h of incubation. A standard antibacterial agent (amikacin&#x02014;30&#x000a0;mcg) was included in each assay as positive control.</p></sec><sec id="Sec8"><title>Antibacterial activity of eugenol derivatives: minimum inhibitory concentration (MIC)</title><p id="Par24">The antibacterial activity of eugenol derivatives was determined by the microdilution method, recommended by the National Committee for Clinical and Laboratory Standard M7-A6<sup>32</sup>. The procedure consisted of testing the pure compounds in six standard Gram (+) and Gram (&#x02212;) bacteriological strains: <italic>P. aeruginosa</italic>, <italic>E. coli</italic>, <italic>S. aureus</italic>, <italic>Streptococcus</italic>, <italic>K. pneumoniae</italic>, <italic>B. cereus</italic>). The Muller Hilton Broth (MHB) was used as medium for the bacterial growth (35&#x000a0;&#x000b0;C, 24&#x000a0;h). After this time, the culture of each bacterial species in the MHB was diluted in the same medium to a concentration of approximately 1&#x02009;&#x000d7;&#x02009;10<sup>8</sup>&#x000a0;CFU/mL (0.5&#x000a0;NTU&#x02014;McFarland scale). Each suspension was further diluted to a final concentration of 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup>&#x000a0;NTU in NaCl solution (0.85%) with 10% MHB. A volume of 100&#x000a0;&#x003bc;L of each suspension was distributed into the wells of the microplates resulting in a final inoculum concentration of 5&#x02009;&#x000d7;&#x02009;10<sup>5</sup>&#x000a0;NTU. The initial solution of the eugenol derivatives was made using 10&#x000a0;mg of each dissolved in 1&#x000a0;mL of DMSO/water (1:1). From this concentration (10&#x000a0;mg/mL), several dilutions were made in distilled water in order to obtain a stock solution of 2000&#x000a0;&#x000b5;g/mL. Further serial dilutions were performed in microplates by addition of MHB (100&#x000a0;&#x000b5;L) to reach a final concentration in the range of 7.8&#x02013;1000&#x000a0;&#x003bc;g/mL. All the experiments were performed in triplicate and the microdilution trays were incubated in bacteriological oven at 35&#x000a0;&#x000b0;C for 24&#x000a0;h. After this period, the antibacterial activity was detected using a colorimetric method by adding 25&#x000a0;&#x000b5;L of the resazurin staining (0.01%) aqueous solution in each well of the microplate. The minimum inhibitory concentration (MIC) was defined as the lowest extract concentration that can inhibit bacterial growth, as indicated by resazurin staining (dead bacterial cells are not able to change the staining color by visual observation&#x02014;blue to red).</p></sec><sec id="Sec9"><title>Free radical scavenging activity (DPPH Assay)</title><p id="Par25">The free radical scavenging activity was determined by the DPPH assay [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. 2&#x000a0;mL of various concentrations (10, 20, 30, 50, 70, 100&#x000a0;&#x000b5;g/mL) of the compounds in methanol was added to 2&#x000a0;mL of a methanol solution of 6.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup> mM DPPH. The decrease in absorbance was determined at 517&#x000a0;nm at room temperature at 0&#x000a0;min, 1&#x000a0;min, and every 5&#x000a0;min for 1&#x000a0;h. For each antioxidant concentration tested, the reaction kinetics was plotted and from these graphs, the absorbance was read after 30&#x000a0;min. Inhibition of the DPPH radical in percent was calculated according to Eq.&#x000a0;<xref rid="Equ1" ref-type="">1</xref>:</p><p id="Par26">Equation&#x000a0;<xref rid="Equ1" ref-type="">1</xref>: Inhibition of the DPPH radical.<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{I (\%)}} = 100\cdot\left(1- {\frac{{\left( { A{\text{sample }} - A{\text{blank}}} \right)}}{{A{\text{blank}}}}} \right)$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mrow><mml:mtext>I (\%)</mml:mtext></mml:mrow><mml:mo>=</mml:mo><mml:mn>100</mml:mn><mml:mo>&#x000b7;</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>A</mml:mi><mml:mrow><mml:mtext>sample</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mo>-</mml:mo><mml:mi>A</mml:mi><mml:mtext>blank</mml:mtext></mml:mrow></mml:mfenced><mml:mrow><mml:mi>A</mml:mi><mml:mtext>blank</mml:mtext></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="13065_2018_407_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>where <italic>A</italic>blank is the absorbance of the control and <italic>A</italic>sample is the absorbance of the sample. Sample concentration providing 50% inhibition (IC<sub>50</sub>) was calculated from the graph plotting inhibition percentage against sample concentration. Tests were carried out in triplicate, and Trolox and gallic acid were used as positive controls.</p></sec></sec><sec sec-type="supplementary-material"><title>Additional file</title><sec id="Sec10"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13065_2018_407_MOESM1_ESM.docx"><caption><p><bold>Additional file 1.</bold> Additional material.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (10.1186/s13065-018-0407-4) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Authors&#x02019; contributions</title><p>FFMS: Realization of derivatives synthesis reactions and organization and writing of the manuscript. FJQM: Characterization by Nuclear Magnetic Resonance Spectroscopy of Hydrogen and Carbon of the obtained derivatives. TLGL: Guidance of the work developed and availability of reagents and laboratory equipment for the development of the work. PGGN: Responsible for obtaining the H and C NMR spectra of the obtained derivatives. AKMC: Evaluation of the antioxidant potential of the derivatives obtained. LMMP: Evaluation of the antibacterial potential of the derivatives. All authors read and approved the final manuscript.</p><sec id="FPar1"><title>Acknowledgements</title><p id="Par27">The authors are grateful to the National Council for Scientific and Technological Development of Brazil (CNPq). We also thank the Northeast Center for the Application and Use of Nuclear Magnetic Resonance (CENAUREMN), at the Federal University of Cear&#x000e1; (UFC), Brazil.</p></sec><sec id="FPar2"><title>Competing interests</title><p id="Par28">The authors declare that they have no competing interests.</p></sec><sec id="FPar3"><title>Availability of data and materials</title><p id="Par29">Manuscript with additional material.</p></sec><sec id="d29e2671"><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec><sec id="FPar4"><title>Funding</title><p id="Par30">Not applicable.</p></sec><sec id="FPar5"><title>Publisher&#x02019;s Note</title><p id="Par31">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kodama</surname><given-names>T</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Dibwe</surname><given-names>DF</given-names></name><etal/></person-group><article-title>Bioorganic and medicinal chemistry letters syntheses of benzophenone-xanthone hybrid polyketides and their antibacterial activities</article-title><source>Bioorg Med Chem Lett</source><year>2017</year><volume>27</volume><fpage>2397</fpage><lpage>2400</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2017.04.017</pub-id><pub-id pub-id-type="pmid">28416134</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Jia</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Emission of volatile esters and transcription of ethylene- and aroma-related genes during ripening of &#x0201c;Pingxiangli&#x0201d; pear fruit (Pyrus ussuriensis Maxim)</article-title><source>Sci Hortic</source><year>2014</year><volume>170</volume><fpage>17</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.scienta.2014.03.004</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>GX</given-names></name><name><surname>Niu</surname><given-names>C</given-names></name><name><surname>Mamat</surname><given-names>N</given-names></name><name><surname>Aisa</surname><given-names>HA</given-names></name></person-group><article-title>Synthesis and in vitro biological evaluation of novel coumarin derivatives containing isoxazole moieties on melanin synthesis in B16 cells and inhibition on bacteria</article-title><source>Bioorg Med Chem Lett</source><year>2017</year><volume>27</volume><fpage>2674</fpage><lpage>2677</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2017.04.039</pub-id><pub-id pub-id-type="pmid">28476568</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>YZ</given-names></name></person-group><article-title>Recent natural products based drug development: a pharmaceutical industry perspective</article-title><source>J Nat Prod</source><year>1998</year><volume>61</volume><fpage>1053</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1021/np9800102</pub-id><pub-id pub-id-type="pmid">9722499</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>DJ</given-names></name><name><surname>Cragg</surname><given-names>GM</given-names></name></person-group><article-title>Natural products as sources of new drugs from 1981&#x02013;2014</article-title><source>J Nat Prod</source><year>2016</year><volume>79</volume><fpage>629</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b01055</pub-id><pub-id pub-id-type="pmid">26852623</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanderlan</surname><given-names>J</given-names></name><name><surname>Esp&#x000ed;ndola</surname><given-names>P</given-names></name><name><surname>Oliveira</surname><given-names>L</given-names></name><etal/></person-group><article-title>Avalia&#x000e7;&#x000e3;o da atividade antimicrobiana e citotoxicidade de derivados aril-semicarbaz&#x000f4;nicos</article-title><source>Rev Bras Farm</source><year>2011</year><volume>92</volume><fpage>171</fpage><lpage>175</lpage></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>TS</given-names></name></person-group><article-title>The multiple faces of Eugenol. A versatile starting material and building block for organic and bio-organic synthesis and a convenient precursor toward bio-based fine chemicals</article-title><source>J Braz Chem Soc</source><year>2015</year><volume>26</volume><fpage>1055</fpage><lpage>1085</lpage></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>MM</given-names></name></person-group><article-title>Eugenol with antioxidant activity inhibits MMP-9 related to metastasis in human fibrosarcoma cells</article-title><source>Food Chem Toxicol</source><year>2013</year><volume>55</volume><fpage>106</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2012.12.050</pub-id><pub-id pub-id-type="pmid">23313798</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kar Mahapatra</surname><given-names>S</given-names></name><name><surname>Chakraborty</surname><given-names>SP</given-names></name><name><surname>Majumdar</surname><given-names>S</given-names></name><etal/></person-group><article-title>Eugenol protects nicotine-induced superoxide mediated oxidative damage in murine peritoneal macrophages in vitro</article-title><source>Eur J Pharmacol</source><year>2009</year><volume>623</volume><fpage>132</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2009.09.019</pub-id><pub-id pub-id-type="pmid">19769960</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hidalgo</surname><given-names>M</given-names></name><name><surname>De la Rosa</surname><given-names>C</given-names></name><name><surname>Carrasco</surname><given-names>H</given-names></name><etal/></person-group><article-title>Antioxidant capacity of eugenol derivates</article-title><source>Quim Nova</source><year>2009</year><volume>32</volume><fpage>1467</fpage><lpage>1470</lpage><pub-id pub-id-type="doi">10.1590/S0100-40422009000600020</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eyambe</surname><given-names>G</given-names></name><name><surname>Canales</surname><given-names>L</given-names></name><name><surname>Banik</surname><given-names>BK</given-names></name></person-group><article-title>Antimicrobial activity of eugenol derivatives</article-title><source>Heterocycl Lett</source><year>2011</year><volume>1</volume><fpage>2231</fpage><lpage>3087</lpage></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awasthi</surname><given-names>PK</given-names></name><name><surname>Dixit</surname><given-names>SC</given-names></name><name><surname>Dixit</surname><given-names>N</given-names></name><name><surname>Sinha</surname><given-names>AK</given-names></name></person-group><article-title>Eugenol derivatives as future potential drugs</article-title><source>Drugs</source><year>2008</year><volume>1</volume><fpage>215</fpage><lpage>220</lpage></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbaszadeh</surname><given-names>S</given-names></name><name><surname>Sharifzadeh</surname><given-names>A</given-names></name><name><surname>Shokri</surname><given-names>H</given-names></name><etal/></person-group><article-title>Antifungal efficacy of thymol, carvacrol, eugenol and menthol as alternative agents to control the growth of food-relevant fungi</article-title><source>Journal de Mycologie Medicale</source><year>2014</year><volume>24</volume><fpage>e51</fpage><lpage>e56</lpage><pub-id pub-id-type="doi">10.1016/j.mycmed.2014.01.063</pub-id><pub-id pub-id-type="pmid">24582134</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W-J</given-names></name><name><surname>Lv</surname><given-names>W-J</given-names></name><name><surname>Li</surname><given-names>L-N</given-names></name><etal/></person-group><article-title>Eugenol confers resistance to Tomato yellow leaf curl virus (TYLCV) by regulating the expression of SlPer1 in tomato plants</article-title><source>New Biotechnol</source><year>2016</year><volume>33</volume><fpage>345</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/j.nbt.2016.01.001</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><article-title>Advances in pharmacological research of eugenol</article-title><source>Curr Opin Complement Altern Med</source><year>2014</year><volume>1</volume><fpage>8</fpage><lpage>11</lpage></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fons&#x000ea;ca</surname><given-names>DV</given-names></name><name><surname>Salgado</surname><given-names>PRR</given-names></name><name><surname>de Neto</surname><given-names>H</given-names></name><etal/></person-group><article-title>Ortho-eugenol exhibits anti-nociceptive and anti-inflammatory activities</article-title><source>Int Immunopharmacol</source><year>2016</year><volume>38</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2016.06.005</pub-id><pub-id pub-id-type="pmid">27355133</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>XW</given-names></name><name><surname>Yang</surname><given-names>YJ</given-names></name><etal/></person-group><article-title>Preventive effect of aspirin eugenol ester on thrombosis in &#x003ba;-carrageenan-induced rat tail thrombosis model</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>1</fpage><lpage>14</lpage></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Morais</surname><given-names>SM</given-names></name><name><surname>Vila-Nova</surname><given-names>NS</given-names></name><name><surname>Bevilaqua</surname><given-names>CML</given-names></name><etal/></person-group><article-title>Bioorganic and medicinal chemistry thymol and eugenol derivatives as potential antileishmanial agents</article-title><source>Bioorg Med Chem</source><year>2014</year><volume>22</volume><fpage>6250</fpage><lpage>6255</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2014.08.020</pub-id><pub-id pub-id-type="pmid">25281268</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadosaki</surname><given-names>LL</given-names></name><name><surname>Falc&#x000e3;o De Sousa</surname><given-names>S</given-names></name><name><surname>Cibene</surname><given-names>J</given-names></name><name><surname>Borges</surname><given-names>M</given-names></name></person-group><article-title>An&#x000e1;lise do uso e da resist&#x000ea;ncia bacteriana aos antimicrobianos em n&#x000ed;vel hospitalar Analysis of use and bacterial resistance to antimicrobial in level hospital</article-title><source>Rev Bras Farm</source><year>2012</year><volume>93</volume><fpage>128</fpage><lpage>135</lpage></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mota</surname><given-names>RA</given-names></name><name><surname>Chaves</surname><given-names>KP</given-names></name><name><surname>Silva</surname><given-names>D</given-names></name><etal/></person-group><article-title>Utiliza&#x000e7;&#x000e3;o indiscriminada de antimicrobianos e sua contribui&#x000e7;&#x000e3;o a multirresit&#x000ea;ncia bacteriana</article-title><source>Braz J vet Res anim Sci</source><year>2005</year><volume>42</volume><fpage>465</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.11606/issn.1678-4456.bjvras.2005.26406</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Golla</surname><given-names>S</given-names></name><name><surname>Faria</surname><given-names>MGI</given-names></name></person-group><article-title>Resist&#x000ea;ncia Bacteriana Como Consequ&#x000ea;ncia Do Uso Inadequado De Antibi&#x000f3;ticos Bacterial Resistance As a Result of Use Unsuitable of Antibiotics</article-title><source>Braz J Surg Clin Res BJSCR</source><year>2013</year><volume>5</volume><fpage>69</fpage><lpage>72</lpage></element-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Vanin AB (2014) Produ&#x000e7;&#x000e3;o, propriedades biol&#x000f3;gicas, antioxidantes e toxicidade do bioaromatizante obtido via esterifica&#x000e7;&#x000e3;o enzim&#x000e1;tica de &#x000f3;leo essencial do cravo-da-&#x000ed;ndia (Caryophyllus aromaticus). 116</mixed-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djurendi&#x00107;</surname><given-names>EA</given-names></name><name><surname>Savi&#x00107;</surname><given-names>MP</given-names></name><name><surname>Jovanovi&#x00107;-&#x00160;anta</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Antioxidant and cytotoxic activity of mono- And bissalicylic acid derivatives</article-title><source>Acta Periodica Technologica</source><year>2014</year><volume>45</volume><fpage>173</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.2298/APT1445173D</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben Mohamed</surname><given-names>H</given-names></name><name><surname>Duba</surname><given-names>KS</given-names></name><name><surname>Fiori</surname><given-names>L</given-names></name><etal/></person-group><article-title>Bioactive compounds and antioxidant activities of different grape (<italic>Vitis vinifera</italic> L.) seed oils extracted by supercritical CO2 and organic solvent</article-title><source>LWT Food Sci Technol</source><year>2016</year><volume>74</volume><fpage>557</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2016.08.023</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caleja</surname><given-names>C</given-names></name><name><surname>Barros</surname><given-names>L</given-names></name><name><surname>Antonio</surname><given-names>AL</given-names></name><etal/></person-group><article-title>A comparative study between natural and synthetic antioxidants: evaluation of their performance after incorporation into biscuits</article-title><source>Food Chem</source><year>2017</year><volume>216</volume><fpage>342</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2016.08.075</pub-id><pub-id pub-id-type="pmid">27596429</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Avila Farias</surname><given-names>M</given-names></name><name><surname>Oliveira</surname><given-names>PS</given-names></name><name><surname>Dutra</surname><given-names>FSP</given-names></name><etal/></person-group><article-title>Eugenol derivatives as potential anti-oxidants: is phenolic hydroxyl necessary to obtain an effect?</article-title><source>J Pharm Pharmacol</source><year>2014</year><volume>66</volume><fpage>733</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1111/jphp.12197</pub-id><pub-id pub-id-type="pmid">24372555</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Xia</surname><given-names>F</given-names></name><name><surname>Bin</surname><given-names>Jin W</given-names></name><etal/></person-group><article-title>Efficient synthesis and antioxidant activities of N-heterocyclyl substituted coenzyme Q analogues</article-title><source>Bioorg Chem</source><year>2016</year><volume>68</volume><fpage>214</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2016.08.008</pub-id><pub-id pub-id-type="pmid">27561631</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>do Nascimento</surname><given-names>P</given-names></name><name><surname>Lemos</surname><given-names>T</given-names></name><name><surname>Bizerra</surname><given-names>A</given-names></name><etal/></person-group><article-title>Antibacterial and antioxidant activities of ursolic acid and derivatives</article-title><source>Molecules</source><year>2014</year><volume>19</volume><fpage>1317</fpage><lpage>1327</lpage><pub-id pub-id-type="doi">10.3390/molecules19011317</pub-id><pub-id pub-id-type="pmid">24451251</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horchani</surname><given-names>H</given-names></name><name><surname>Ben Salem</surname><given-names>N</given-names></name><name><surname>Zarai</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Enzymatic synthesis of eugenol benzoate by immobilized Staphylococcus aureus lipase: optimization using response surface methodology and determination of antioxidant activity</article-title><source>Biores Technol</source><year>2010</year><volume>101</volume><fpage>2809</fpage><lpage>2817</lpage><pub-id pub-id-type="doi">10.1016/j.biortech.2009.10.082</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahim</surname><given-names>NHCA</given-names></name><name><surname>Asari</surname><given-names>A</given-names></name><name><surname>Ismail</surname><given-names>N</given-names></name><name><surname>Osman</surname><given-names>H</given-names></name></person-group><article-title>Synthesis and antibacterial study of eugenol derivatives</article-title><source>Asian J Chem</source><year>2017</year><volume>29</volume><fpage>22</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.14233/ajchem.2017.20100</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendre</surname><given-names>SR</given-names></name><name><surname>Rajput</surname><given-names>JD</given-names></name></person-group><article-title>Outlooks on medicinal properties of eugenol and its synthetic derivatives</article-title><source>Nat Prod Chem Res</source><year>2016</year></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro-Santos</surname><given-names>R</given-names></name><name><surname>Andrade</surname><given-names>M</given-names></name><name><surname>de Melo</surname><given-names>NR</given-names></name><etal/></person-group><article-title>Biological activities and major components determination in essential oils intended for a biodegradable food packaging</article-title><source>Ind Crops Prod</source><year>2017</year><volume>97</volume><fpage>201</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2016.12.006</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamed</surname><given-names>OA</given-names></name><name><surname>Mehdawi</surname><given-names>N</given-names></name><name><surname>Taha</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Synthesis and antibacterial activity of novel curcumin derivatives containing heterocyclic moiety</article-title><source>Iran J Pharm Res</source><year>2013</year><volume>12</volume><fpage>47</fpage><lpage>56</lpage></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro-Santos</surname><given-names>R</given-names></name><name><surname>Andrade</surname><given-names>M</given-names></name><name><surname>de Melo</surname><given-names>NR</given-names></name><etal/></person-group><article-title>Biological activities and major components determination in essential oils intended for a biodegradable food packaging</article-title><source>Ind Crops Prod</source><year>2017</year><volume>97</volume><fpage>201</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2016.12.006</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albano</surname><given-names>M</given-names></name><name><surname>Alves</surname><given-names>FCB</given-names></name><name><surname>Andrade</surname><given-names>BFMT</given-names></name><etal/></person-group><article-title>Antibacterial and anti-staphylococcal enterotoxin activities of phenolic compounds</article-title><source>Innov Food Sci Emerg Technol</source><year>2016</year><volume>38</volume><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.ifset.2016.09.003</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Findik</surname><given-names>E</given-names></name><name><surname>Ceylan</surname><given-names>M</given-names></name><name><surname>Elmasta</surname><given-names>M</given-names></name></person-group><article-title>Isoeugenol-based novel potent antioxidants: synthesis and reactivity</article-title><source>Eur J Med Chem</source><year>2011</year><volume>46</volume><fpage>4618</fpage><lpage>4624</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2011.07.041</pub-id><pub-id pub-id-type="pmid">21843909</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagha-Benamrouche</surname><given-names>S</given-names></name><name><surname>Madani</surname><given-names>K</given-names></name></person-group><article-title>Phenolic contents and antioxidant activity of orange varieties (<italic>Citrus sinensis</italic> L. and <italic>Citrus aurantium</italic> L.) cultivated in Algeria: peels and leaves</article-title><source>Ind Crops Prod</source><year>2013</year><volume>50</volume><fpage>723</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2013.07.048</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barroso</surname><given-names>MF</given-names></name><name><surname>Ramalhosa</surname><given-names>MJ</given-names></name><name><surname>Alves</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Total antioxidant capacity of plant infusions: assessment using electrochemical DNA-based biosensor and spectrophotometric methods</article-title><source>Food Control</source><year>2016</year><volume>68</volume><fpage>153</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.foodcont.2016.03.029</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manach</surname><given-names>C</given-names></name><name><surname>Scalbert</surname><given-names>A</given-names></name><name><surname>Morand</surname><given-names>C</given-names></name><etal/></person-group><article-title>Bioavailability, polyphenols: food sources and bioavailability</article-title><source>Am J Clin Nutr</source><year>2004</year><volume>79</volume><fpage>727</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1093/ajcn/79.5.727</pub-id><pub-id pub-id-type="pmid">15113710</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sucupira</surname><given-names>NR</given-names></name><name><surname>Da</surname><given-names>Silva AB</given-names></name><name><surname>Pereira</surname><given-names>G</given-names></name><name><surname>Da</surname><given-names>Costa JN</given-names></name></person-group><article-title>Methods for measuring antioxidant activity of fruits</article-title><source>UNOPAR Cient&#x000ed;fica Ci&#x000ea;ncias Biol&#x000f3;gicas e da Sa&#x000fa;de</source><year>2014</year><volume>14</volume><fpage>263</fpage><lpage>269</lpage></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinrichs</surname><given-names>GBMBPHJ</given-names></name></person-group><article-title>Asymmetric synthesis of (M)-2-hydroxymethyl-1-(2-Hydroxy-4,6-dimethylphenyl)naphthalene via a configurationally unstable biaryl lactone</article-title><source>Org Synth</source><year>2002</year><volume>79</volume><fpage>72</fpage><pub-id pub-id-type="doi">10.15227/orgsyn.079.0072</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkenes</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>HC</given-names></name><name><surname>Lynch</surname><given-names>GJ</given-names></name></person-group><article-title>Solvomercuration-demercuration. 8. Oxymercuration&#x02013;demercuration of methoxy-, hydroxy-, and acetoxy-substituted alkenes&#x02019;</article-title><source>J Org Chem</source><year>2016</year><volume>4537</volume><fpage>531</fpage><lpage>538</lpage></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>FFM</given-names></name><name><surname>Ferreira</surname><given-names>DA</given-names></name><name><surname>Monte</surname><given-names>FJQ</given-names></name><name><surname>de Lemos</surname><given-names>TLG</given-names></name></person-group><article-title>Synthesis of chiral esters and alcohols via enantioselective esterification with <italic>Citrus aurantium</italic> peels as biocatalyst</article-title><source>Ind Crops Prod</source><year>2017</year><volume>96</volume><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2016.11.013</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burt</surname><given-names>HHP</given-names></name></person-group><article-title>Styrene oxide</article-title><source>Org Synth</source><year>1928</year><volume>8</volume><fpage>102</fpage><pub-id pub-id-type="doi">10.15227/orgsyn.008.0102</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cit&#x000f2;</surname><given-names>AM</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>BQ</given-names></name><name><surname>Lopes</surname><given-names>JAD</given-names></name><etal/></person-group><article-title>S&#x000ed;ntese de regiois&#x000f4;meros quirais a partir de D-manitol: obten&#x000e7;&#x000e3;o de uma mistura de &#x000e1;lcoois acetil&#x000ea;nicos</article-title><source>Quim Nova</source><year>2009</year><volume>32</volume><fpage>2355</fpage><lpage>2359</lpage><pub-id pub-id-type="doi">10.1590/S0100-40422009000900023</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand-Williams</surname><given-names>W</given-names></name><name><surname>Cuvelier</surname><given-names>ME</given-names></name><name><surname>Berset</surname><given-names>C</given-names></name></person-group><article-title>Use of a free radical method to evaluate antioxidant activity</article-title><source>LWT Food Sci Technol</source><year>1995</year><volume>28</volume><fpage>25</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/S0023-6438(95)80008-5</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>OP</given-names></name><name><surname>Bhat</surname><given-names>TK</given-names></name></person-group><article-title>DPPH antioxidant assay revisited</article-title><source>Food Chem</source><year>2009</year><volume>113</volume><fpage>1202</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2008.08.008</pub-id></element-citation></ref></ref-list></back></article>